USPTO serial 85623332
APTAMIR
Reviewed by CopyMark Law Group
Status 601
- Filing date
- Status date
- Registration date
- —
- Examiner
- —
- Law office
- NEW APPLICATION PROCESSING
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with APTAMIR?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark D. Godler
MARK D. GODLER KAYE SCHOLER LLP425 PARK AVE FL 12NEW YORK, NY 10022-3598UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Micro RNA targeted drug development and research in the field of biotech therapeutics; development of RNA based pharmaceutical drugs and therapeutic compounds; development of drugs for the pharmaceutical and biotech industries for the treatment of a wide variety of diseases and other conditions, including cancer, fibrosis, liver disease, and renal diseases | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 17, 2012 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 16, 2012 | MAB1 | ABANDONMENT NOTICE MAILED - EXPRESS ABANDONMENT | — |
| May 16, 2012 | ABN1 | ABANDONMENT - EXPRESS MAILED | — |
| May 15, 2012 | EXAR | TEAS EXPRESS ABANDONMENT RECEIVED | — |
| May 15, 2012 | NWAP | NEW APPLICATION ENTERED | — |